The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis

Hepatology

Volumn 32, Issue 6, 2000, Pages 1196-1199

  Corpechot, Christophe ^a   Carrat, Fabrice ^b   Bonnand, Anne Marie ^b   Poupon, Renée Eugénie ^b   Poupon, Raoul ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

URSODEOXYCHOLIC ACID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL MODEL; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033658752     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.20240     Document Type: Article

References (22)

1. Ursodiol for the long-term treatment of primary biliary cirrhosis
2. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
3. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
4. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis
5. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis
6. Characterisation of patients with a complete biochemical response to ursodeoxycholic acid
7. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis
8. A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
9. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: Results of a double-blind controlled multicentric trial
10. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid
11. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
12. The Markov process in medical prognosis
13. Application of multistage Markov modeling to malignant melanoma progression
14. Multi-state models and diabetic retinopathy
15. Time course of histological progression in primary biliary cirrhosis
16. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression
17. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients
18. A Markov model for analysing cancer markers and disease states in survival studies
19. Statistical analysis of the stages of HIV infection using a Markov model
20. Primary biliary cirrhosis
21. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
22. Accuracy of staging in primary biliary cirrhosis